NOTE 3 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)

9 Months Ended

Sep. 30, 2019

Accounting Policies [Abstract]

The following table provides information about disaggregated revenue by product mix for the three and nine months ended September 30, 2019 and 2018:

The following table provides information about disaggregated revenue by product mix for the three and nine months ended September 30, 2019 and 2018:

	Three Months Ended September 30,				Nine Months Ended September 30,
	2019		2018		2019		2018
Prescription vitamins	$	2,550,330	$	3,261,459	$	7,309,174	$	10,797,861
IMVEXXY		4,772,354		212,076		9,904,744		212,076
BIJUVA		490,705		—		624,987		—
ANNOVERA		399,952		—		399,952		—
License revenue		15,506,400		—		15,506,400		—
Net revenue	$	23,719,741	$	3,473,535	$	33,745,257	$	11,009,937